Skip to main content
TipRanks
Go Ultimate75% OFF

TenNor Therapeutics Suzhou Ltd. Class H (6872) Stock Statistics & Valuation Metrics

Total Valuation

TenNor Therapeutics Suzhou Ltd. Class H has a market cap or net worth of HKD 3.90B. The enterprise value is HKD 10.69B.

Market Cap
HKD 3.90B
Enterprise Value
HKD 10.69B

Share Statistics

TenNor Therapeutics Suzhou Ltd. Class H has 52,328,926 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
52,328,926
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

TenNor Therapeutics Suzhou Ltd. Class H’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -57.19%.

Return on Equity (ROE)
-1.00
Return on Assets (ROA)
-0.67
Return on Invested Capital (ROIC)
-57.19%
Return on Capital Employed (ROCE)
-0.63
Revenue Per Employee
0
Profits Per Employee
-2.74M
Employee Count
56
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of TenNor Therapeutics Suzhou Ltd. Class H is -21.08. TenNor Therapeutics Suzhou Ltd. Class H’s PEG ratio is -0.21.

PE Ratio
-21.08
PS Ratio
0.00
PB Ratio
20.99
Price to FCF
-37.26
Price to Operating Cash Flow
-37.04
PEG Ratio
-0.21

Income Statement

In the last 12 months, TenNor Therapeutics Suzhou Ltd. Class H had revenue of 0 and earned -153.24M in profits. Earnings per share was -2.96.

Revenue
0
Gross Profit
0
Operating Income
-118.67M
Pretax Income
-153.24M
Net Income
-153.24M
EBITDA
-150.18M
Earnings Per Share (EPS)
-2.96

Cash Flow

In the last 12 months, operating cash flow was -33.14M and capital expenditures -74,853, giving a free cash flow of -33.21M billion.

Operating Cash Flow
-33.14M
Free Cash Flow
-33.21M
Free Cash Flow per Share
-1.69

Dividends & Yields

TenNor Therapeutics Suzhou Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.68%
Earnings Yield
-4.74%

Stock Price Statistics

Beta
-0.55
52-Week Price Change
-65.26%
50-Day Moving Average
99.02
200-Day Moving Average
162.75
Relative Strength Index (RSI)
37.87
Average Volume (3m)
102.40K

Important Dates

TenNor Therapeutics Suzhou Ltd. Class H upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date
Aug 26, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

TenNor Therapeutics Suzhou Ltd. Class H as a current ratio of 5.02, with Debt / Equity ratio of 18.62%

Current Ratio
5.02
Quick Ratio
5.02
Debt to Market Cap
0.00
Net Debt to EBITDA
1.03
Interest Coverage Ratio
-80.07

Taxes

In the past 12 months, TenNor Therapeutics Suzhou Ltd. Class H has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

TenNor Therapeutics Suzhou Ltd. Class H EV to EBITDA ratio is -20.71, with an EV/FCF ratio of -35.49.

EV to Sales
0.00
EV to EBITDA
-20.71
EV to Free Cash Flow
-35.49
EV to Operating Cash Flow
-35.67

Balance Sheet

TenNor Therapeutics Suzhou Ltd. Class H has HKD 183.76M in cash and marketable securities with HKD 28.65M in debt, giving a net cash position of HKD 155.11M billion.

Cash & Marketable Securities
HKD 183.76M
Total Debt
HKD 28.65M
Net Cash
HKD 155.11M
Net Cash Per Share
HKD 2.96
Tangible Book Value Per Share
HKD 0.00

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Scores

Smart Score
8
AI Score
41